[go: up one dir, main page]

AU3462799A - Progression related genes and methods of use therefor - Google Patents

Progression related genes and methods of use therefor

Info

Publication number
AU3462799A
AU3462799A AU34627/99A AU3462799A AU3462799A AU 3462799 A AU3462799 A AU 3462799A AU 34627/99 A AU34627/99 A AU 34627/99A AU 3462799 A AU3462799 A AU 3462799A AU 3462799 A AU3462799 A AU 3462799A
Authority
AU
Australia
Prior art keywords
methods
related genes
use therefor
progression related
progression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34627/99A
Inventor
Paul B. Fisher
Nan Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3462799A publication Critical patent/AU3462799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU34627/99A 1998-03-31 1999-03-31 Progression related genes and methods of use therefor Abandoned AU3462799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8019398P 1998-03-31 1998-03-31
US60080193 1998-03-31
PCT/US1999/007187 WO1999050289A2 (en) 1998-03-31 1999-03-31 Transformation progression-related genes and their use

Publications (1)

Publication Number Publication Date
AU3462799A true AU3462799A (en) 1999-10-18

Family

ID=22155843

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34627/99A Abandoned AU3462799A (en) 1998-03-31 1999-03-31 Progression related genes and methods of use therefor

Country Status (2)

Country Link
AU (1) AU3462799A (en)
WO (1) WO1999050289A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625169B2 (en) * 1987-03-23 1992-07-02 Imperial Chemical Industries Plc Molecular markers
US5085983A (en) * 1988-08-19 1992-02-04 City Of Hope Detection of human tumor progression and drug resistance
US5539096A (en) * 1994-09-08 1996-07-23 Universite De Montreal Genes differentially expressed in metastatic and non-metastatic rat rhabdomyosarcoma cell lines
US6146877A (en) * 1997-03-21 2000-11-14 The Trustees Of Columbia University In The City Of New York Identification of the progression elevated gene-3 and uses thereof

Also Published As

Publication number Publication date
WO1999050289A3 (en) 2000-01-20
WO1999050289A2 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
AU6037199A (en) Rac-like genes from maize and methods of use
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
PL335226A1 (en) Gene sequencer and related methods
AU6117000A (en) Novel polynucleotides and method of use thereof
AU2468401A (en) Underreamer and method of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU3068699A (en) Skin equivalent and methods of forming and using same
AU3622600A (en) Metalloproteinases and methods of use therefor
AU2972199A (en) Apoptosis inducing molecule ii and methods of use
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU3118297A (en) Sok-1 and methods of use
AU1451200A (en) Dual reporter system and methods of use therefor
AU6412599A (en) Oxybutynin formulations and methods of use
AU3695099A (en) Ese genes and proteins
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU2584699A (en) Immediate early genes and methods of use therefor
AU3789199A (en) Raq genes and their uses
AU6387699A (en) Rac-like genes and methods of use
AU3462799A (en) Progression related genes and methods of use therefor
AU4810700A (en) Signal transduction genes and methods of use
AU6084598A (en) Antibiotic-ligand conjugates and methods of use thereof
AU4860299A (en) (zap-3) tumor associated genes and their uses
AU2567599A (en) Anti-ccr1 antibodies and methods of use therefor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase